Company profile: Biognosys
1.1 - Company Overview
Company description
- Provider of integrated proteomics solutions and contract research services for pharma and biotech, including TrueDiscovery for deep, unbiased profiling across drug development, TrueTarget for drug target deconvolution and binding site mapping, TrueSignature custom panels for absolute protein quantification, Spectronaut mass spectrometry analysis software, and PQ500 kit for quantifying 500+ plasma proteins.
Products and services
- Contract Research Services: Biognosys delivers clinical-development-focused proteomics contract research services, supporting pharma and biotech research and clinical development with the best possible systems for researchers’ protein analysis needs
- TrueDiscovery: Biognosys architects integrated proteomics systems across the entire drug development pipeline, enabling deep, unbiased profiling of tissue and biofluids proteomes for precise quantification
- Spectronaut: Biognosys develops MS-based software for analyzing mass spectrometry data, delivering high precision and depth in protein quantification for robust proteome analysis
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biognosys
ProKnow
HQ: United States
Website
- Description: Provider of cloud-based software solutions to improve quality in radiation oncology worldwide, delivering a high-impact, low-cost investment in quality, consistency, and improved patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProKnow company profile →
Labviva
HQ: United States
Website
- Description: Provider of an AI-powered life sciences purchasing and inventory platform that integrates with existing eProcurement software to enhance supply chain transparency and reduce complexity, offering supplier catalog management, comprehensive analytics and real-time reporting, intuitive search, multi-device purchasing, and integrated billing, plus a scientifically enabled application that captures enriched product data from papers to enable direct product comparison.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labviva company profile →
Abbott
HQ: United States
Website
- Description: Provider of lab data management solutions, including LIMS, SDMS, and ELN, that integrate with current systems and can be rapidly configured to fit unique workflows without adding complexity or interrupting daily operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abbott company profile →
XtalPi
HQ: United States
Website
- Description: Provider of integrated digital drug discovery and development solutions combining AI, cloud computing, and wet lab validation. Offerings include ID4 platform, AI + physics-based models to predict drug-like properties, synthetic chemistry services with the XtalDynamics automation system, XupremAb biologics discovery, and targeted libraries of drug-like molecules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XtalPi company profile →
Chemos
HQ: Germany
Website
- Description: Provider of ready-to-use solutions for laboratories and the chemical industry, offering raw materials for organic synthesis, active ingredients for the pharmaceutical and food industries, and various catalysts and crosslinkers; also provides manual filling lines for solid and liquid.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chemos company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biognosys
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biognosys
2.2 - Growth funds investing in similar companies to Biognosys
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biognosys
4.2 - Public trading comparable groups for Biognosys
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →